【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets/Categories Covered 10
3.1 In Vitro Diagnostics 10
3.1.1 Infectious Immunology 10
4 Company Snapshot 11
4.1 Key Facts 11
4.2 Company Overview 11
4.3 Financial Performance 11
4.4 SWOT Snapshot 11
4.5 Business Overview 12
4.6 Major Products and Services 13
4.6.1 Overview 13
5 History 14
6 SWOT Analysis 16
6.1 Overview 16
6.2 OraSure Technologies, Inc. Strengths 16
6.2.1 Increase in Current Asset Turnover 16
6.2.2 Broad Product Portfolio 16
6.2.3 Focused Research & Development Activities 17
6.3 OraSure Technologies, Inc. Weaknesses 17
6.3.1 High Dependency on the US Market 17
6.3.2 Low Debt to Equity Ratio 17
6.4 OraSure Technologies, Inc. Opportunities 18
6.4.1 Growing In Vitro Diagnostics Market 18
6.4.2 Strong Pipeline Products 18
6.4.3 Acquisition of DNA Genotek (DNAG) 18
6.5 OraSure Technologies, Inc. Threats 19
6.5.1 Regulatory Environment 19
6.5.2 Industry Consolidation Challenges 19
6.5.3 Intense Competition 19
7 Competitors 20
8 Competative Landscape 21
8.1 In Vitro Diagnostics (Infectious Immunology), Global, Market Share (%), 2011 21
8.2 OraSure Technologies, Inc., In Vitro Diagnostics (Infectious Immunology), by Region, Market Share (2011) 23
8.3 OraSure Technologies, Inc., In Vitro Diagnostics (Infectious Immunology), by Country, Market Share (2011) 25
9 Key Employees 27
10 Key Employee Biographies 28
11 Company Statement 29
12 Locations And Subsidiaries 32
12.1 Head Office 32
12.2 Other Locations & Subsidiaries 32
13 Financial Deals Landscape 33
13.1 OraSure Technologies, Inc., Deals Volume Summary, 2007 to YTD 2012 33
13.2 Partnerships 35
13.2.1 OraSure Technologies Signs Licensing Agreement With Inverness Medical Innovations 35
13.2.2 DNA Genotek Enters Into Distribution Agreement With Abyntek Biopharma 36
13.2.3 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 37
13.2.4 OraSure Technologies Expands Agreement With Schering-Plough 38
13.2.5 OraSure Technologies Enters Into Agreement With Schering-Plough 39
13.3 Equity Offering 40
13.3.1 Orasure Technologies Files Shelf Registration Statement For Public Offering Of Securities For $200 Million 40
13.3.2 OraSure Technologies Completes Public Offering Of Common Stock For $75 Million 41
13.4 Acquisition 43
13.4.1 OraSure Technologies Completes Acquisition Of DNA Genotek 43
14 Recent Developments 45
14.1 Strategy And Business Planning 45
14.1.1 Aug 19, 2010: Amerinet Partners With St. Barnabas-Bronx And OraSure Technologies To Implement Efficient HIV Testing Procedures 45
14.2 Financial Announcements 45
14.2.1 Nov 07, 2012: OraSure Technologies Reports Revenue Of $22.1m In Q3 2012 45
14.2.2 Aug 07, 2012: OraSure Technologies Reports Revenue Of $22.6m In Q2 2012 47
14.2.3 May 02, 2012: OraSure Technologies Reports Revenue Of $20.9m In Q1 2012 47
14.2.4 Feb 08, 2012: OraSure Technologies Reports Revenue Of $81.9m In 2011 48
14.2.5 Nov 02, 2011: OraSure Technologies Reports Revenues Of $21.7m In Q3 2011 49
14.2.6 Aug 03, 2011: OraSure Technologies Reports Revenues Of $19.1m In Q2 2011 51
14.2.7 May 04, 2011: OraSure Technologies Reports Revenues Of $17.4m In Q1 2011 52
14.2.8 Feb 09, 2011: OraSure Technologies Reports Revenues Of $75.01m In 2010 52
14.2.9 Nov 09, 2010: OraSure Reports Net Revenues Of $19.03 Million For Q3 2010 53
14.2.10 Aug 04, 2010: OraSure Reports Net Loss Of $0.5 Million For Q2 2010 54
14.2.11 May 05, 2010: OraSure Technologies Reports Revenues Of $17.9 Million In Q1 2010 55
14.2.12 Feb 10, 2010: OraSure Technologies Reports Revenues Of $77 Million In 2009 55
14.2.13 Nov 04, 2009: OraSure Reports Net Income Of $1.8 Million In Q3 2009 57
14.2.14 Aug 05, 2009: OraSure Technologies Posts Net Loss Of $5.2 Million In Q2 2009 58
14.2.15 May 06, 2009: OraSure Technologies Posts Net Loss Of $1.6 Million In Q1 2009 58
14.2.16 Feb 11, 2009: OraSure Technologies Reports 2008 Results 59
14.2.17 Nov 05, 2008: OraSure Technologies Reports 3Q 2008 Results 61
14.2.18 Aug 05, 2008: OraSure Technologies Reports 2Q 2008 Results 62
14.2.19 May 06, 2008: OraSure Technologies Declares Q1 2008 Results 62
14.2.20 Feb 12, 2008: OraSure Technologies Declares Q4 2007 Results 63
14.2.21 Oct 30, 2007: OraSure Technologies Declares Q3 2007 Results 65
14.2.22 Jul 31, 2007: OraSure Technologies Reports Q2 2007 Results 66
14.2.23 May 08, 2007: OraSure Technologies Reports Q1 2007 Results 66
14.2.24 Feb 13, 2007: OraSure Technologies Reports 2006 Results 67
14.2.25 Nov 01, 2006: OraSure Technologies Reports Q3 2006 Results 68
14.2.26 Aug 08, 2006: OraSure Technologies Reports Q2 2006 Results 69
14.3 Corporate Communications 70
14.3.1 Nov 10, 2011: OraSure Technologies Appoints Gerald M Ostrov To Board 70
14.3.2 Apr 07, 2011: OraSure Appoints Stephen Tang To Board Of Directors 71
14.3.3 Jan 04, 2011: OraSure Appoints Tony Zezzo As New Executive Vice President, Marketing And Sales 71
14.3.4 May 13, 2010: OraSure Technologies Eliminates 18 Positions At Its Bethlehem Plants 72
14.3.5 Sep 10, 2009: OraSure Technologies Appoints Robert Gregg As VP, Regulatory Affairs And Quality Assurance 72
14.3.6 Nov 17, 2008: OraSure Technologies CEO To Present At Lazard Conference 73
14.3.7 Sep 10, 2008: OraSure Technologies Appoints Vice President, International Sales 73
14.3.8 Jan 02, 2008: OraSure Appoints VP, Government And External Affairs 73
14.3.9 Oct 05, 2006: OraSure Technologies Elects New Board Members 74
14.3.10 May 22, 2006: OraSure Technologies Appoints New Board Member 74
14.4 Legal and Regulatory 74
14.4.1 Nov 19, 2009: OraSure Technologies Settles Patent Lawsuit With Inverness Medical And Church & Dwight 74
14.5 Government and Public Interest 75
14.5.1 Nov 21, 2012: OraSure Supports New Routine HIV Screening Recommendations By US Preventive Services Task Force 75
14.5.2 Nov 01, 2011: OraSure Supports AAP Updated Recommendations For Routine HIV Screening For Adolescents 76
14.6 Product News 77
14.6.1 Oct 09, 2012: OraSure Announces Availability Of OraQuick In-Home HIV Test To Consumers Across US 77
14.6.2 Jul 03, 2012: OraSure Receives FDA Clearance For Its OraQuick In-Home HIV Test 77
14.6.3 Jun 27, 2012: OraSure Supports Rapid HIV Testing Initiatives In Recognition Of 18th Annual National HIV Testing Day 78
14.6.4 May 18, 2012: OraSure Technologies Issues Statement On CDC Proposed Draft Guidelines For Testing Of Baby Boomers For Hepatitis C 79
14.6.5 May 15, 2012: OraSure’s OraQuick In-Home HIV Test Receives Unanimous Positive Recommendation From FDA Advisory Committee 79
14.6.6 Apr 04, 2012: FDA Sets Date For Advisory Committee On Review Of OraQuick Rapid HIV-1/2 Test 80
14.6.7 Jan 03, 2012: OraSure Makes Final FDA Submission For Approval Of OTC Rapid HIV Test 80
14.6.8 Nov 29, 2011: OraSure Technologies Receives CLIA Waiver For OraQuick HCV Rapid Test 81
14.6.9 Nov 29, 2011: OraSure Technologies Receives CLIA Waiver For OraQuick HCV Rapid Test For Use With Fingerstick Whole Blood And Venous Whole Blood Specimens 82
14.6.10 Aug 09, 2011: OraSure Closes Enrollment In Final Clinical Study For OraQuick Rapid HIV Over-The-Counter Test 82
14.6.11 Mar 23, 2011: OraSure Technologies Submits CLIA Waiver Application For OraQuick HCV Rapid Test 83
14.6.12 Feb 22, 2011: OraSure Technologies Receives FDA Approval For OraQuick HCV Rapid Test Using Fingerstick Whole Blood 83
14.6.13 Jan 11, 2011: OraSure Technologies To Launch OraSure QuickFlu Rapid Flu A+B Test 84
14.6.14 Dec 13, 2010: OraSure Initiates Enrollment In Final Clinical Study For OraQuick Rapid HIV Over-The-Counter Test 84
14.6.15 Nov 22, 2010: OraSure Technologies Receives FDA Approval To Conduct Final Phase Of Clinical Studies For OraQuick OTC HIV Test 85
14.6.16 Aug 04, 2010: OraSure Delays FDA Filing Of Oral Version Of OraQuick HCV Test 85
14.6.17 Jun 25, 2010: OraSure Technologies Receives FDA Approval For OraQuick HCV Rapid Test 85
14.6.18 Jan 07, 2010: OraSure Submits Additional Data For PMA Approval Of OraQuick Rapid HCV Test 86
14.6.19 Dec 15, 2009: OraSure Gains CE Mark Approval For OraQuick Rapid HCV Antibody Test 86
14.6.20 Sep 24, 2009: OraSure Technologies Supplies OraQuick ADVANCE Rapid HIV-1/2 Antibody Test For 36-Months To Premier Purchasing Partners 87
14.6.21 Jan 28, 2009: OraSure Technologies Announces US FDA Approval For OraQuick ADVANCE 12-Month Shelf Life Dating 87
14.6.22 Nov 05, 2008: OraSure Technologies To Sell OraQuick ADVANCE Rapid HIV-1/2 Antibody Test Directly To US Hospitals 88
14.6.23 Nov 04, 2008: OraSure’s Intercept Oral Fluid Drug Test Results Comparable To Urine Drug Screening According To Landmark Five-Year Analysis 88
14.6.24 Oct 28, 2008: OraSure Technologies Files For FDA Approval Of OraQuick Rapid Hepatitis C Test 88
14.6.25 Oct 13, 2008: OraSure Technologies Helps Expand Access To Rapid HIV Testing In Recognition Of National Latino AIDS Awareness Day 89
14.6.26 Feb 11, 2008: Schering-Plough and OraSure Technologies Sign International Collaboration For Rapid Point-of-Care Oral Hepatitis C Test 89
14.6.27 Oct 26, 2005: FDA To Consider Quick HIV Self Test 89
14.7 Product Approvals 90
14.7.1 Jul 03, 2012: OraSure Receives FDA Clearance For Its OraQuick In-Home HIV Test 90
14.7.2 Nov 29, 2011: OraSure Technologies Receives CLIA Waiver For OraQuick HCV Rapid Test For Use With Fingerstick Whole Blood And Venous Whole Blood Specimens 90
14.7.3 Feb 22, 2011: OraSure Technologies Receives FDA Approval For OraQuick HCV Rapid Test Using Fingerstick Whole Blood 91
14.7.4 Jun 25, 2010: OraSure Technologies Receives FDA Approval For OraQuick HCV Rapid Test 91
14.7.5 Jan 28, 2009: OraSure Technologies Announces US FDA Approval For OraQuick ADVANCE 12-Month Shelf Life Dating 92
14.8 Clinical Trials 92
14.8.1 Aug 09, 2011: OraSure Closes Enrollment In Final Clinical Study For OraQuick Rapid HIV Over-The-Counter Test 92
14.8.2 Dec 13, 2010: OraSure Initiates Enrollment In Final Clinical Study For OraQuick Rapid HIV Over-The-Counter Test 93
14.8.3 Nov 22, 2010: OraSure Technologies Receives FDA Approval To Conduct Final Phase Of Clinical Studies For OraQuick OTC HIV Test 93
14.8.4 Nov 04, 2008: OraSure’s Intercept Oral Fluid Drug Test Results Comparable To Urine Drug Screening According To Landmark Five-Year Analysis 94
14.9 Other Significant Developments 94
14.9.1 Oct 30, 2012: Hospitals, Healthcare Providers To Benefit From New Premier Agreements For Rapid Diagnostic Test Kits 94
14.9.2 Sep 22, 2009: Meridian Bioscience, OraSure Technologies Sign Agreement With Premier 94
14.9.3 Nov 17, 2008: OraSure Technologies CEO To Present At Lazard Conference 94
15 Appendix 95
15.1 Research Methodology 96
15.2 Secondary Research 96
15.3 Primary Research 96
15.4 Models 97
15.5 Forecasts 97
15.6 Expert Panels 97
15.7 GlobalData Consulting 97
15.8 Currency Conversion 98
15.9 Contact Us 99
15.10 Disclaimer 99
【レポート販売概要】
■ タイトル：OraSure Technologies, Inc.：市場シェア分析■ 英文：OraSure Technologies, Inc. Market Share Analysis
■ 発行日：2013年2月15日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160400
■ 調査対象地域：グローバル
- 光ファイバー・テスト装置の世界市場：OTDR（光パルス試験器）、OPM、OLTS、RFTS、光スペクトルアナライザーFiber optics is the science of transmitting data, voice, and images by the passage of light through thin, transparent fibers. A fiber optic consists of a bundle of glass threads, each of which is capable of transmitting messages modulated onto light waves. Fiber optic testing is gaining value due to its growing applications in the installation and maintenance of fiber optic cables. The major end-u …
- 洋上風力発電の世界市場2015-2019About Offshore Wind Power Offshore wind power is the generation of electricity from wind by constructing wind farms in water bodies. It is estimated to be one of the cheapest and cleanest forms of electricity generation. Offshore wind turbines are larger in size and have greater wind speed compared with onshore wind turbines. Offshore wind power offers various advantages compared with onshore wind …
- オーストラリアのエネルギー産業分析：Analyzing the Energy Industry in AustraliaThe global energy industry has explored many options to meet the growing energy needs of industrialized economies wherein production demands are to be met with supply of power from varied energy resources worldwide. There has been a clearer realization of the finite nature of oil resources and the ever higher pushing demand for energy. The world has yet to stabilize on the complex geopolitical und …
- 世界のハイブリッドクラウド市場In todays business environment, organizations strive to meet the constantly changing global business dynamics. Most of the organizations view IT as a tool to be agile and to have a sustainable business success. At the same time, rising IT costs have become a major concern and cost cutting is the current business objective of corporations. Public cloud services have revolutionized the IT industry a …
- 世界のエンドポイントセキュリティ市場：ソリューション別（エンドポイント保護プラットフォーム及びエンドポイント検出＆応答）、サービス別、展開モード別、組織規模別、業種別（ヘルスケア、小売およびeコマース、政府）、地域別The global endpoint security market size to grow at a CAGR of 7.6% during the forecast period The global endpoint security market size is projected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 7.6% during the forecast period. The endpoint security industry is driven by the increasing number of endpoint and Bring Your Own Devices (BYO …
- 三次元測定技術の世界市場予測（～2024年）“3D metrology market projected to grow at 9.3% CAGR during 2018–2024” The 3D metrology market was valued at USD 9.5 billion in 2018 and is expected to reach USD 16.2 billion by 2024, at a CAGR of 9.3% from 2018 to 2024. The major driving factors for the 3D metrology market are the highly accurate inspection owing to 3D data for modelling and analysis, focus on quality control, and increase in R&D …
- 非接触型ICカードの世界市場2016-2020About Contactless Smart Cards Smart cards are pocket-sized cards that are embedded with integrated circuits. These smart cards can be used for individual identification and authentication by organizations in various sectors, including banking, financial services, and insurance (BFSI); transportation; government; and healthcare. Furthermore, these smart cards can be used by enterprises to provide a …
- グローバル通信市場におけるトップ10企業分析Synopsis The ICD Research Global Top 10 Telecom Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global telecom industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated. Nippon Telegraph and Telephone Corporation AT&T Inc. Ver …
- 世界の音声分析（スピーチ・アナリティクス）市場動向及び予測(2014-2019)The speech analytics market analysis consists of various types of solutions and services, applications, deployment types, organization size, verticals, and regions. The overall market size is found by adding up the market size of each solution and services such as speech engine, indexing and analysis, software query, engine reports and dashboards, professional services and support, maintenance ser …
- 世界の工業煙道ガス処理システム及びサービス市場動向（～2019）Industrial flue gas treatment systems and services market to be driven by increasingly stringent regulations and increasing coal-fired power generation capacity The combustion of fossil fuels generates huge amounts of harmful pollutants. These pollutants have adverse effects on human health and on the environment. Hence, the regulations for controlling sulfur oxides, nitrogen oxides, particulate m …
- 肥料混合物の世界市場（～2019）The expansion of the global fertilizer mixture industry is forecast to reach 2.2% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 2.6%. Currently, diammonium phosphate accounts for 53.2% of the global demand while the remaining market share is divided between nitrogen-phosphorus-potassium fertilizers (22.0%) ,monoammonium phosphate and mixes wi …
- DNO International ASA：石油・ガスバリューチェーン分析レポート2013DNO International ASA Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "DNO International ASA" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “DNO International ASA”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report e …
- 先進創傷被覆材：企業動向Advanced Wound Dressings - Current and Future Players Summary Advanced dressings have steadily replaced traditional bandages and gauze materials in the treatment of a variety of wound indications, such as trauma wounds, burns, and chronic ulcerations. As fluid management, infection control, and physical protection become increasingly critical in wound healing, advanced dressings enjoy a greater ro …
- ムコ多糖症II型(ハンター症候群)：グローバル臨床試験レビュー（2014年上半期）Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) clinical trial scenario. This report provides elemental information and data relating to the clin …
- グローバル空港産業サーベイ（2013-2014）：市場動向、購買戦略Why was the report written? This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global airport industry executives; it provides data and analysis on buyer expenditure, procurement, and developments within the global airports industry. The report includes key topics such as global airport industry buyer expenditure and procurement behaviors and stra …
